Serum Levels of Soluble Interleukin-2 Receptor in Renal Cell Carcinoma

Author： Matsumoto T.   Furukawa A.   Sumiyoshi Y.   Akiyama K.-y.   Kanayama H.-o.   Kagawa S.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.51, Iss.1, 1998-01, pp. : 145-149

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanism of Increased Serum Soluble Interleukin-2 Receptor Levels in Patients on Continuous Ambulatory Peritoneal Dialysis

By Takemasa Atsuo   Yorioka Noriaki   Oda Hiroaki   Amimoto Dai   Ito Takafumi   Yamakido Michio  

Scandinavian Journal of Urology and Nephrology, Vol. 35, Iss. 2, 2001-03 ,pp. : 141-146

Informa Healthcare

Access to resources Recommend Favorite

Immunotherapy for renal cell carcinoma: the era of interleukin-2-based treatment

By Taneja S.S.   Pierce W.   Figlin R.   Belldegrun A.  

Urology, Vol. 45, Iss. 6, 1995-06 ,pp. : 911-924

Elsevier

Access to resources Recommend Favorite

Serum Soluble Interleukin-2 Receptor as a Predictor of Lymph Node Metastasis in Early Gastric Cancer

By  

Digestive Surgery, Vol. 19, Iss. 1, 2002-04 ,pp. : 9-14

Karger

Access to resources Recommend Favorite

Soluble Fas in serum from patients with renal cell carcinoma - a protein tyrosine phosphatase that associates with Fas

By Nonomura N.   Nishimura K.   Ono Y.   Fukui T.   Harada Y.   Takaha N.   Takahara S.   Okuyama A.  

Urology, Vol. 55, Iss. 1, 2000-01 ,pp. : 151-155

Elsevier

Access to resources Recommend Favorite

Soluble endothelial cell protein C receptor and thrombomodulin levels after renal transplantation

By Keven Kenan   Elmaci Semiha   Sengul Sule   Akar Nejat   Egin Yonca   Genc Volkan   Erturk Sehsuvar   Erbay Bulent  

International Urology and Nephrology, Vol. 42, Iss. 4, 2010-12 ,pp. : 1093-1098

Springer Publishing Company

Access to resources Recommend Favorite